PHARMACOECONOMIC EDUCATION AT MEDICAL SCHOOLS IN TURKEY

Author(s)

Tulunay F, Gulmez S, Ergun HAnkara University School of Medicine, Ankara, Turkey

OBJECTIVE: There is an increasing interest in pharmacoeconomics among physicians. However, as can be seen from multiple examples, the concept is prone for abuse and misuse. In this study we evaluated the curriculum of the Turkish medical schools. We looked at whether they have any formal pharmacoeconomic lectures or they are planning on introducing pharmacoecononmics lectures within the pharmacology, clinical pharmacology or other courses. METHODS: A questionnaire was prepared to evaluate the pharmacoeconomics education at 35 Medical Schools in Turkey. We got in contact with the head of the Pharmacology Departments either by phone or by face to face interviews. The questionnaire was composed of questions regarding the presence of pharmacoeconomics lectures; i.e. if already in curriculum, at which year, and for how many hours. If no pharmacoeconomics lecture exists, is there any intention of including it in the curriculum. RESULTS: We got replies from 27 (77%) of the Pharmacology Departments. Pharmacoeconomy lecture is currently given only at two niversities (Ankara, Atatürk). All but two of the other departments communicated that pharmacoeconomics lectures will be given in the future. CONCLUSION: Pharmacoeconomics is an important part of clinical pharmacology. However the concept is not part of the medical school curriculum in most universities. There is a trend towards giving pharmacoeconomics classes at fourth or fifth year within clinical pharmacology lectures. Even though most of the pharmacology departments informed that they are going to include pharmacoeconomics into the curriculum, currently practicing physicians lack the necessary knowledge. In our opinion, in addition to the inclusion of pharmacoeconomics in the medical school curriculums, special programs are also required for physicians who had not had a formal pharmacoeconomic course during their undergraduate education. There is an increasing responsibility for pharmacology/clinical pharmacology departments to take a role in such programs.

Conference/Value in Health Info

2005-05, ISPOR 2005, Washington, DC, USA

Value in Health, Vol. 8, No. 3 (May/June 2005)

Code

PHP15

Topic

Health Policy & Regulatory, Health Service Delivery & Process of Care

Topic Subcategory

Approval & Labeling, Prescribing Behavior, Pricing Policy & Schemes

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×